Open Access Publikationen von Angehörigen der MedUni Wien [4]: Published online 2016 Apr

Open Access-Publizieren ohne Zusatzkosten für AutorInnen der MedUni Wien

Die Medizinische Universität Wien hat mit dem Springer-Verlag ein neues Lizenzmodell „Springer Compact“ vereinbart. Publiziert kann in über 1.600 Subskriptionszeitschriften von Springer Open Access ohne zusätzliche AutorInnengebühren werden.  Mehr Infos–>

Im Van Swieten Blog können Sie  kontinuierlich die Open Access Publikationen von Angehörigen der MedUni Wien nachlesen:

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia

  • 1Department of Hematology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium.
  • 2Department of Cell Therapy and Hematology, San Bortolo Hospital, Viale Rodolfi, 37, 36100, Vicenza, Italy.
  • 3Dalhousie University, QEII-Bethune Building, Suite 442 Bethune Building, 1276 South Park Street, Halifax, NS, B3H 2Y9, Canada.
  • 4St. George Hospital, UNSW Medicine, UNSW, Sydney, 2052, Australia.
  • 5Clinical Center Department of Medicine, Thrombosis Haemostasis Center, University of Debrecen, H-4012 Debrecen, Nagyerdei krt. 98. POB.: 20, Debrecen, Hungary.
  • 6Medizinische Universitaet Wien, Universitaetsklinik fuer Innere Medizin I Waehringer Guertel 18-20, A-1090, Vienna, Austria.
  • 7University Hospital Masaryk University, Jihlavská 340/20, 625 00, Brno, Czech Republic.
  • 8Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, 801 NE 13th, CHB 333, Oklahoma City, OK, 73104, USA.
  • 9Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA, 91320, USA.

Ann Hematol. 2016; 95: 1077–1087. Published online 2016 Apr 30. doi: 10.1007/s00277-016-2682-2

PMCID:

PMC4889627

Article
PubReader
PDF–1.3M
Citation

***************************************

Prognostic impact of breast cancer subtypes in elderly patients

  • 1Comprehensive Cancer Center, Vienna, Austria.
  • 2Clinical Division of Oncology, Department of Medicine 1, Medical University of Vienna, Vienna, Austria.
  • 3Comprehensive Cancer Center, Vienna, Austria.
  • 4Clinical Division of Oncology, Department of Medicine 1, Medical University of Vienna, Vienna, Austria.
  • 5Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • 6Department of Surgery, Medical University of Vienna, Vienna, Austria.
  • 7Comprehensive Cancer Center, Vienna, Austria.
  • 8Clinical Division of Oncology, Department of Medicine 1, Medical University of Vienna, Vienna, Austria.

Breast Cancer Res Treat. 2016; 157: 91–99. Published online 2016 Apr 23. doi: 10.1007/s10549-016-3787-y

PMCID:

PMC4866984

Article
PubReader
PDF–600K
Citation

***************************************

Monitoring Allergen Immunotherapy Effects by Microarray

  • 1Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Waehringer Guertel 18-20, 3Q, 1090 Vienna, Austria.

Curr Treat Options Allergy. 2016; 3: 189–203. Published online 2016 Apr 20. doi: 10.1007/s40521-016-0084-2

PMCID:

PMC4891384

Article
PubReader
PDF–1.0M
Citation

***************************************

Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients

  • 1Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • 2Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
  • 3Department of Internal Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • 4Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
  • 5Department of Laboratory Medicine, Division of Clinical Microbiology, Medical University of Vienna, Vienna, Austria.
  • 6Department of Internal Medicine I, Division of Infectious Diseases and Tropical Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

Ann Hematol. 2016; 95: 1115–1120. Published online 2016 Apr 19. doi: 10.1007/s00277-016-2672-4

PMCID:

PMC4889618

Article
PubReader
PDF–275K
Citation

***************************************

Intra-cystic concentrations of albendazole-sulphoxide in human cystic echinococcosis: a systematic review and analysis of individual patient data

  • 1Division of Infectious Diseases and Tropical Medicine Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • 2Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
  • 3University Hospital for Infectious Diseases Fran Mihaljevic, Zagreb, Croatia.
  • 4Department of Medical Parasitology, Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
  • 5Department of Surgery, Medical University of Vienna, Vienna, Austria.
  • 6Department of Biomedical Imaging and Image-guided Therapie, Medical University of Vienna, Vienna, Austria.
  • 7Division of Infectious Diseases and Tropical Medicine Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • 8Centre de Recherches Médicales de Lambaréné, Lambaréné, Gabon.
  • 9Institut für Tropenmedizin, Universität Tübingen, Tübingen, Germany.

Parasitol Res. 2016; 115: 2995–3001. Published online 2016 Apr 16. doi: 10.1007/s00436-016-5054-x

PMCID:

PMC4958128

Article
PubReader
PDF–513K
Citation

***************************************

Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases

  • 1Division of Infectious Diseases, University Hospital Carl Gustav Carus at the TU Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
  • 2Division Public Health, Austrian Agency for Health and Food Safety (AGES), Vienna, Austria.
  • 3Hospital Pharmacy, Munich Municipal Hospital, Munich, Germany.
  • 4Institute for Hygiene, Microbiology and Tropical Medicine (IHMT), National Reference Centre for Nosocomial Infections and Antimicrobial Resistance, Elisabethinen Hospital Linz, Linz, Austria.
  • 5Department of Infectious Disease Medical Clinic II, Goethe-University Frankfurt, Frankfurt, Germany.
  • 6Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
  • 7Hospital Pharmacy, Schwarzwald-Baar Hospital, Villingen-Schwenningen, Germany.
  • 8Department of Hospital Epidemiology and Infectiology, Sana Kliniken AG, Ismaning, Germany.
  • 9Department for Hygiene and Infection Control, Danube Hospital, Vienna, Austria.
  • 10Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, Graz, Austria.
  • 11Division of Infection Control and Infectious Diseases, University Hospital RWTH Aachen, Aachen, Germany.
  • 12Institute of Hygiene and Environmental Medicine, Charité, University Medicine Berlin, Berlin, Germany.
  • 13Department for Clinical Pharmacy and Drug Information, Landesapotheke, Landeskliniken Salzburg (SALK), Salzburg, Austria.
  • 14Department of Infection Control and Hospital Epidemiology, Medical University of Vienna, Vienna, Austria.
  • 15Clinic for General Internal Medicine, Infectious Diseases, Pneumology and Osteology, Klinikum Leverkusen, Leverkusen, Germany.
  • 16Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • 17Department of Medicine 1, Gastroenterology, Pneumology and Endocrinology, University Hospital Erlangen, Erlangen, Germany.
  • 18Department of Antibiotics and Infection Control, Krankenanstalt Rudolfstiftung, Vienna, Austria.
  • 19Medical Department of Infection and Tropical Medicine, Kaiser Franz Josef Hospital, Vienna, Austria.
  • 20Division of Infectious Diseases, Department of Medicine, Freiburg University Medical Center, Freiburg, Germany.

Infection. 2016; 44: 395–439. Published online 2016 Apr 11. doi: 10.1007/s15010-016-0885-z

PMCID:

PMC4889644

Article
PubReader
PDF–1.1M
Citation

***************************************

Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update

  • 1Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.
  • 2First Medical Department, Rudolfstiftung Hospital, Vienna, Austria.
  • 3Medical Department, Hochzirl – Natters Hospital, Hochzirl, Austria.
  • 4Department of Medical Genetics, Clinical and Molecular Pharmacology, Medical University of Innsbruck, Innsbruck, Austria.
  • 5Department of Internal Medicine, Bregenz Hospital, Bregenz, Austria.
  • 6First Medical Department, Paracelsus Medical University, Salzburg, Austria.
  • 7Department of Cardiology, Wels Hospital, Wels, Austria.
  • 8Third Medical Department, Medical University of Vienna, Vienna, Austria.
  • 9Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036, Graz, Austria.
  • 10First Medical Department, Hanusch-Krankenhaus, Vienna, Austria.
  • 11Department of Internal Medicine and Cardiology, Feldkirch Hospital, Feldkirch, Austria.
  • 12Medical Department, Linz General Hospital, Linz, Austria.
  • 13Third Medical Department, Elisabethinen Hospital, Linz, Austria.
  • 14First Medical Department, Mistelbach Hospital, Mistelbach, Austria.
  • 15Department of Internal Medicine, Baden-Mödling Hospital, Mödling, Austria.
  • 16Third Medical Department, Medical University of Innsbruck, Innsbruck, Austria.
  • 17First Department of Neurology, Kepler University Clinic, Linz, Austria.
  • 18Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.

Wien Klin Wochenschr. 2016; 128: 216–228. Published online 2016 Apr 6. doi: 10.1007/s00508-016-0993-x

PMCID:

PMC4839054

Article
PubReader
PDF–406K
Citation

***************************************

[18F]FE@SNAP—a specific PET tracer for melanin-concentrating hormone receptor 1 imaging?

  • 1Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • 2Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Vienna, Austria.
  • 3Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria.
  • 4Department of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
  • 5Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. markus.mitterhauser@meduniwien.ac.at.
  • 6Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Vienna, Austria. markus.mitterhauser@meduniwien.ac.at.
  • 7Ludwig Boltzmann Institute for Applied Diagnostics, Vienna, Austria.

EJNMMI Res. 2016; 6: 31. Published online 2016 Apr 1. doi: 10.1186/s13550-016-0186-7

PMCID:

PMC4816952

Article
PubReader
PDF–1.9M
Citation

***************************************

32nd International Austrian Winter Symposium: Zell am See, the Netherlands. 20-23 January 2016

Langsteger W, Rezaee A, Loidl W, Geinitz HS, Fitz F, Steinmair M, Broinger G, Pallwien-Prettner L, Beheshti M, Imamovic L, Beheshti M, Rendl G, Hackl D, Tsybrovsky O, Steinmair M, Emmanuel K, Moinfar F, Pirich C, Langsteger W, Bytyqi A, Karanikas G, Mayerhöfer M, Koperek O, Niederle B, Hartenbach M, Beyer T, Herrmann K, Czernin J, Rausch I, Rust P, DiFranco MD, Lassen M, Stadlbauer A, Mayerhöfer ME, Hartenbach M, Hacker M, Beyer T, Binzel K, Magnussen R, Wei W, Knopp MU, Flanigan DC, Kaeding C, Knopp MV, Leisser A, Nejabat M, Hartenbach M, Kramer G, Krainer M, Hacker M, Haug A, Lehnert W, Schmidt K, Kimiaei S, Bronzel M, Kluge A, Wright CL, Binzel K, Zhang J, Wuthrick E, Maniawski P, Knopp MV, Blaickner M, Rados E, Huber A, Dulovits M, Kulkarni H, Wiessalla S, Schuchardt C, Baum RP, Knäusl B, Georg D, Bauer M, Wulkersdorfer B, Wadsak W, Philippe C, Haslacher H, Zeitlinger M, Langer O, Bauer M, Feldmann M, Karch R, Wadsak W, Zeitlinger M, Koepp MJ, Asselin MC, Pataraia E, Langer O, Zeilinger M, Philippe C, Dumanic M, Pichler F, Pilz J, Hacker M, Wadsak W, Mitterhauser M, Nics L, Steiner B, Hacker M, Mitterhauser M, Wadsak W, Traxl A, Wanek T, Kryeziu K, Mairinger S, Stanek J, Berger W, Kuntner C, Langer O, Mairinger S, Wanek T, Traxl A, Krohn M, Stanek J, Filip T, Sauberer M, Kuntner C, Pahnke J, Langer O, Svatunek D, Denk C, Wilkovitsch M, Wanek T, Filip T, Kuntner-Hannes C, Fröhlich J, Mikula H, Denk C, Svatunek D, Wanek T, Mairinger S, Stanek J, Filip T, Fröhlich J, Mikula H, Kuntner-Hannes C, Balber T, Singer J, Fazekas J, Rami-Mark C, Berroterán-Infante N, Jensen-Jarolim E, Wadsak W, Hacker M, Viernstein H, Mitterhauser M, Denk C, Svatunek D, Sohr B, Mikula H, Fröhlich J, Wanek T, Kuntner-Hannes C, Filip T, Pfaff S, Philippe C, Mitterhauser M, Hartenbach M, Hacker M, Wadsak W, Wanek T, Halilbasic E, Visentin M, Mairinger S, Stieger B, Kuntner C, Trauner M, Langer O, Lam P, Aistleitner M, Eichinger R, Artner C, Eidherr H, Vraka C, Haug A, Mitterhauser M, Nics L, Hartenbach M, Hacker M, Wadsak W, Kvaternik H, Müller R, Hausberger D, Zink C, Aigner RM, Cossío U, Asensio M, Montes A, Akhtar S, Te Welscher Y, van Nostrum R, Gómez-Vallejo V, Llop J, VandeVyver F, Barclay T, Lippens N, Troch M, Hehenwarter L, Egger B, Holzmannhofer J, Rodrigues-Radischat M, Pirich C, Pötsch N, Rausch I, Wilhelm D, Weber M, Furtner J, Karanikas G, Wöhrer A, Mitterhauser M, Hacker M, Traub-Weidinger T, Cassou-Mounat T, Balogova S, Nataf V, Calzada M, Huchet V, Kerrou K, Devaux JY, Mohty M, Garderet L, Talbot JN, Stanzel S, Pregartner G, Schwarz T, Bjelic-Radisic V, Liegl-Atzwanger B, Aigner R, Stanzel S, Quehenberger F, Aigner RM, Marković AK, Janković M, Jerković VM, Paskaš M, Pupić G, Džodić R, Popović D, Fornito MC, Familiari D, Koranda P, Polzerová H, Metelková I, Henzlová L, Formánek R, Buriánková E, Kamínek M, Thomson WH, Lewis C, Thomson WH, O’Brien J, James G, Notghi A, Huber H, Stelzmüller I, Wunn R, Mandl M, Fellner F, Lamprecht B, Gabriel M, Fornito MC, Leonardi G, Thomson WH, O’Brien J, James G, Hudzietzová J, Sabol J, Fülöp M.

EJNMMI Res. 2016; 6(Suppl 1): 32. Published online 2016 Apr 18. doi: 10.1186/s13550-016-0168-9

PMCID:

PMC4835428

Article
PubReader
PDF–529K
Citation

******************************************

Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study

  • 1Department of Urology, A. C. Camargo Hospital, São Paulo, Brazil.
  • 2Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • 3Department of Urology, Rennes University Hospital, Rennes, France.
  • 4Department of Pathology, Medical University Vienna, Vienna, Austria.
  • 5Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA.
  • 6Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
  • 7Academic Department of Urology, Faculté de Médecine Pierre et Marie Curie, La Pitié-Salpetrière Hospital, Assistance Publique-Hôpitaux de Paris, University Paris 6, Paris, France.
  • 8Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, Canada.
  • 9Department of Urology, University of Michigan Cancer Center, Ann Arbor, MI, USA.
  • 10Division of Urology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA.
  • 11Department of Pathology, Rennes University Hospital, Rennes, France.
  • 12Department of Urology, University Hospital Basel, Basel, Switzerland.
  • 13Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • 14Department of Urology, Vita Salute San Raffaele University, Milan, Italy.
  • 15Department of Urology and Comprehensive Cancer Center, Medical University of Vienna, Vienna General Hospital, Währinger Gürtel 18-20, 1090, Vienna, Austria. sfshariat@gmail.com.
  • 16Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA. sfshariat@gmail.com.
  • 17Department of Urology, Weill Cornell Medical College, New York, NY, USA.

World J Urol. 2017; 35(1): 113–120. Published online 2016 Apr 29. doi: 10.1007/s00345-016-1835-1

PMCID:

PMC5233747

Article
PubReader
PDF–864K
Citation

**************************************

Magnetic resonance imaging of temporomandibular joint with anterior disk dislocation without reposition – long-term results

  • 1Department of Fixed and Removable Prosthodontics, University Clinic of Dentistry, Sensengasse 2a, 1090, Vienna, Austria. margit.bristela@meduniwien.ac.at.
  • 2Department of Fixed and Removable Prosthodontics, University Clinic of Dentistry, Sensengasse 2a, 1090, Vienna, Austria.
  • 3Dental Office, Vienna, Austria.
  • 4Institute of Environmental Health, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15, 1090, Wien, Austria.
  • 5Diagnostic Center Urania, Laurenzerberg 2, 1010, Vienna, Austria.

Clin Oral Investig. 2017; 21(1): 237–245. Published online 2016 Apr 16. doi: 10.1007/s00784-016-1800-9

PMCID:

PMC5203833

Article
PubReader
PDF–2.1M
Citation

********************************

Dentifrices for children differentially affect cell viability in vitro

  • 1Department of Preventive, Restorative and Pediatric Dentistry, School of Dental Medicine, University of Bern, Freiburgstrasse 7, CH-3010, Bern, Switzerland. barbara.cvikl@zmk.unibe.ch.
  • 2Department of Conservative Dentistry & Periodontology, Medical University of Vienna, Sensengasse 2a, A-1090, Vienna, Austria. barbara.cvikl@zmk.unibe.ch.
  • 3Department of Preventive, Restorative and Pediatric Dentistry, School of Dental Medicine, University of Bern, Freiburgstrasse 7, CH-3010, Bern, Switzerland.
  • 4Department of Conservative Dentistry & Periodontology, Medical University of Vienna, Sensengasse 2a, A-1090, Vienna, Austria.
  • 5Department of Oral Biology, Medical University of Vienna, Sensengasse 2a, A-1090, Vienna, Austria.

Clin Oral Investig. 2017; 21(1): 453–461. Published online 2016 Apr 6. doi: 10.1007/s00784-016-1813-4

PMCID:

PMC5203830

Article
PubReader
PDF–666K
Citation

****************************************

A new measure for in vivo thrombin activity in comparison with in vitro thrombin generation potential in patients with hyper- and hypocoagulability

1Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
2Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria
3Department of Medicine, Thrombosis and Hemostasis Program, McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC USA
Cihan Ay, ta.ca.neiwinudem@ya.nahic.

corresponding authorCorresponding author.

Clin Exp Med. 2017; 17(2): 251–256. Published online 2016 Apr 19. doi: 10.1007/s10238-016-0417-2

PMCID:

PMC5403851

Article
PubReader
PDF–447K
Citation

Alle Beiträge zu Open Access–>

Schreibe einen Kommentar